Epodure: Additional Phase I/II data

Additional data from an ongoing, open-label, Israeli Phase I/II trial showed that hemoglobin levels in patients treated with 40 IU/kg/day Epodure (n=2) increased by 1.1-1.2 g/dL at week 4 vs. 0.5-0.75...